A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
Conditions
Interventions
- BIOLOGICAL: Attenuvax
- BIOLOGICAL: M-M-R-II
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators